• Fri, May 6, 2022
Do Kim Maintained (TVTX) at Buy with Decreased Target to $40 on, May 6th, 2022
Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Decreased Target from $42 to $40 on, May 6th, 2022.
Do has made no other calls on TVTX in the last 4 months.
There is 1 other peer that has a rating on TVTX. Out of the 1 peers that are also analyzing TVTX, 0 agree with Do's Rating of Hold.
This is the rating of the analyst that currently disagrees with Do
- Ed Arce of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $45 on, Monday, February 28th, 2022
Like: 👍
